To functionally test the importance of PPM1D in neuroblastoma and medulloblastoma, we investigated the effects of genetic or pharmacological inhibition of WIP1 and demonstrated that blocking the expression or activity of WIP1 suppressed both neuroblastoma and medulloblastoma growth in vivo. The gene discussed is PPM1D; the disease is medulloblastoma.